These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 34165800)
1. The Role of Pharmacogenetics in Smoking. El-Boraie A; Tyndale RF Clin Pharmacol Ther; 2021 Sep; 110(3):599-606. PubMed ID: 34165800 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of nicotine and associated smoking behaviors. Tanner JA; Chenoweth MJ; Tyndale RF Curr Top Behav Neurosci; 2015; 23():37-86. PubMed ID: 25655887 [TBL] [Abstract][Full Text] [Related]
3. 'Smoking genes': a genetic association study. Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326 [TBL] [Abstract][Full Text] [Related]
4. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. Ray R; Tyndale RF; Lerman C J Neurogenet; 2009; 23(3):252-61. PubMed ID: 19169923 [TBL] [Abstract][Full Text] [Related]
5. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism. Wen L; Jiang K; Yuan W; Cui W; Li MD Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942 [TBL] [Abstract][Full Text] [Related]
6. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Salloum NC; Buchalter ELF; Chanani S; Espejo G; Ismail MS; Laine RO; Nageeb M; Srivastava AB; Trapp N; Trillo L; Vance E; Wenzinger M; Hartz SM; David SP; Chen LS Pharmacogenomics; 2018 Jul; 19(10):861-871. PubMed ID: 29914292 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations. Claw KG; Beans JA; Lee SB; Avey JP; Stapleton PA; Scherer SE; El-Boraie A; Tyndale RF; Nickerson DA; Dillard DA; Thummel KE; Robinson RF Nicotine Tob Res; 2020 May; 22(6):910-918. PubMed ID: 31241144 [TBL] [Abstract][Full Text] [Related]
11. Genetics and smoking behavior. Schnoll RA; Johnson TA; Lerman C Curr Psychiatry Rep; 2007 Oct; 9(5):349-57. PubMed ID: 17915073 [TBL] [Abstract][Full Text] [Related]
12. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior. Tyndale RF; Sellers EM Ther Drug Monit; 2002 Feb; 24(1):163-71. PubMed ID: 11805739 [TBL] [Abstract][Full Text] [Related]
13. Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers. Chenoweth MJ; Sylvestre MP; Contreras G; Novalen M; O'Loughlin J; Tyndale RF Drug Alcohol Depend; 2016 Jan; 158():139-46. PubMed ID: 26644138 [TBL] [Abstract][Full Text] [Related]
14. SNPs within CHRNA5-A3-B4 and CYP2A6/B6 are associated with smoking dependence but not with tobacco dependence treatment outcomes in the Czech population. Hubacek JA; Pankova A; Stepankova L; Zvolska K; Adamkova V; Lanska V; Kralikova E Gene; 2017 Mar; 606():35-38. PubMed ID: 28069549 [TBL] [Abstract][Full Text] [Related]
15. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women. Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993 [TBL] [Abstract][Full Text] [Related]